Altamira Therapeutics Ltd.: common_shares_outstanding
| Value | {"unit": "shares", "value": 14964261, "concept": "dei:EntityCommonStockSharesOutstanding"} |
|---|---|
| Period | (as of 2021-12-31) |
| Status | current |
| Entity | Altamira Therapeutics Ltd. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/87f92ba5-f3c3-4f8d-accd-80630c12e1cb
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-22-019292Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001601936/common-shares-outstanding/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/87f92ba5-f3c3-4f8d-accd-80630c12e1cb
History
- no predecessors — first report